logo

For the Inventor, By the Inventor

NL

Pharming Intellectual Property Bv


USPTO Granted Patents = 11

% Expired Patents = 18.2


Trademarks = 10

Forward Citations = 96

Loading Chart...
Loading Chart...

20 inventors (with patents filed for the assignee):

goldMedal Johannes Henricus Nuijens (5 out of 5 patents)

silverMedal Frank Pieper (4 out of 7 patents)

bronzeMedal Maurice Mannesse (3 out of 3 patents)

4.  Maria Grazia De Simoni (3 out of 3 patents)

5.  Gijsbertus Johannes Ziere (3 out of 3 patents)

6.  Graham McCreath (2 out of 4 patents)

7.  Erik Jordahl Forsberg (1 out of 7 patents)

8.  Kathryn Margaret Nelson (1 out of 1 patent)

9.  Michael William Mosesson (1 out of 1 patent)

10.  Anthony Pusateri (1 out of 1 patent)

11.  Mourad Salaheddine (1 out of 1 patent)

12.  Marc Peter Elvira Maria Klyutmans (1 out of 1 patent)

13.  Pieter Cornelis Johannes Maria Streng (1 out of 1 patent)

14.  Udell Michael (1 out of 1 patent)

15.  Jan Henricus Nuijens (1 out of 3 patents)


11 patents:

1. 9546381 - Use of anticoagulants in the production of recombinant proteins in the milk of transgenic animals (2017-01-17),
2. 9408366 - Milking device (2016-08-09),
3. 9211318 - Use of C1 inhibitor for the prevention of ischemia-reperfusion injury (2015-12-15),
4. 8415288 - Use of C1 inhibitor for the prevention of ischemia-reperfusion injury (2013-04-09),
5. RE43691 - C1 inhibitor with short half-life transient treatment (2012-09-24),
6. 8071532 - Use of C1 inhibitor for the prevention of ischemia-reperfusion injury (2011-12-06),
7. RE42704 - Production of fibrinogen in transgenic animals (2011-09-12),
8. 7544853 - C1 inhibitor with short half-life transient treatment (2009-06-09),
9. 7211650 - Purification of fibrinogen from fluids by precipitation and hydrophoic chromatography (2007-05-01),
10. 7067713 - C1 Inhibitor produced in the milk of transgenic non-human mammals (2006-06-27),
11. 7045677 - Fusion proteins incorporating lysozyme (2006-05-16),
Company Overview
Pharming Intellectual Property B.V. is a biotechnology company based in the Netherlands, specializing in the development of innovative therapies for rare diseases. The organization focuses on recombinant protein technology, particularly in the area of enzyme replacement therapies. With a commitment to addressing unmet medical needs, Pharming leverages its proprietary technology to create treatments that improve patient outcomes. The company is dedicated to advancing its research and expanding its therapeutic offerings in the global healthcare landscape.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

11 Patents

#22 in

#569 in Netherlands

#51,761 in the World

NL
NL

Pharming Intellectual Property Bv

Forward Citations = 96

20 inventors:

goldMedal Johannes Henricus Nuijens (5 out of 5 patents)

silverMedal Frank Pieper (4 out of 7 patents)

bronzeMedal Maurice Mannesse (3 out of 3 patents)

4.  Maria Grazia De Simoni (3 out of 3 patents)

5.  Gijsbertus Johannes Ziere (3 out of 3 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Pharming Intellectual Property Bv. Retrieved from https://idiyas.com/company/pharming-intellectual-property-bv

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…